Concepedia

THEODOR FEHR

TF

Statistics

Publications

6

Citations

373

H-Index

6

Active since

1977

Affiliations

Novartis (Switzerland)(Current)

Sanden (Japan)

THEODOR FEHR is an author at Novartis (Switzerland) specializing in microbiology, biochemistry, and drug discovery.

Publications per year

1977–1999

6

Publications

6

Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110. I. Taxonomy, Fermentation, Isolation and Biological Activity.

Jean‐Jacques Sanglier, Valérie Quesniaux, THEODOR FEHR et al. · The Journal of Antibiotics · 1999 · 148 citations · Full text

, , +6

Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110. II. Structure Elucidation, Stereochemistry and Physico-chemical Properties.

THEODOR FEHR, Jörg Kallen, Lukas Oberer et al. · The Journal of Antibiotics · 1999 · 104 citations · Full text

, , +6

Antascomicins A, B, C, D and E. Novel FKBP12 Binding Compounds from a Micromonospora Strain.

THEODOR FEHR, Jean‐Jacques Sanglier, W. Schüler et al. · The Journal of Antibiotics · 1996 · 63 citations · Full text

, , +3

Mutalomycin, a new polyether antibiotic: Taxonomy, fermentation, isolation and characterization.

THEODOR FEHR, HAMILTON D. KING, Max Kuhn · The Journal of Antibiotics · 1977 · 24 citations · Full text

, , +7

Isolation of an isomer of FK-506 from fermentation of Streptomyces tsukubaensis and its chemical synthesis from FK-506

Maximilian A. Grassberger, THEODOR FEHR, Amarylla Horvath et al. · Tetrahedron · 1992 · 18 citations

, , +8

1–5 of 6